Código QR (código de barras bidimensional)

Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial

As a stepping stone toward evaluation in infants, the safety and immunogenicity of an investigational 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (12vPHiD-CV) was assessed in toddlers. 12vPHiD-CV contains CRM197-conjugated capsular polysaccharides of seroty...

ver descrição completa

Na minha lista:
Principais autores: Michael Horn, Ulrich Behre, Magali Traskine, Kurt Dobbelaere, Dorota Borys
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2021-05-01
coleção:Human Vaccines & Immunotherapeutics
Assuntos:
pneumococcal conjugate vaccine
phid-cv
safety
booster dose
immunogenicity
toddlers
Acesso em linha:http://dx.doi.org/10.1080/21645515.2020.1810493
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados